About half of prostate cancers are due to gene fusions linking the androgen-regulated transmembrane protease TMPRSS2 with the transcription factor ERG [119,120] resulting in a massive androgen-dependent overexpression of ERG. This evidence concerns the gene ERG and prostate cancer.